Phase I/II Study of Docetaxel and S-1 Combination Therapy for Advanced Non-small Cell Lung Cancer
- Conditions
- Advanced Non-small Cell Lung Cancer
- Registration Number
- JPRN-C000000281
- Lead Sponsor
- The Tokyo Cooperative Oncology Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Not provided
1)Serious infectious disease 2)Patient receiving flucytosine 3)Apparent ineterstitial pneumonia or pulmonary fibrosis 4)Medical history of allergy or hypersensitivity reactions to S-1 or any drug containing polysorbate 80 5)Edema need for treatment 6)Pleural or pericardial effusion requiring treatment 7)Patient intermittent oxygen supply 8)Serious concomitant disease 9)Cardiac infarction within 6 month 10)Supra vena cava syndrome patient 11)Pregnant or lactation women, or women with known or suspected pregnancy. 12)Man who wont let to pregnancy 13)Clinical symptom of brain metastases 14)Medical history of serious allergy reactions to any drug 15)Inappropriate patients for this study judged by the physicians.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method